As on Wednesday, Invesco Ltd (NYSE: IVZ) started slowly as it slid -0.18% to $28.25, before settling in for the price of $28.3 at the close. Taking a more long-term approach, IVZ posted a 52-week range of $11.60-$29.05.
The Financial Sector giants’ yearly sales growth during the last 5-year period was -1.69%. Meanwhile, its Annual Earning per share during the time was -1.69%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 16.30%. This publicly-traded company’s shares outstanding now amounts to $445.09 million, simultaneously with a float of $442.10 million. The organization now has a market capitalization sitting at $12.57 billion.
Invesco Ltd (IVZ) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Asset Management industry. Invesco Ltd’s current insider ownership accounts for 0.67%, in contrast to 92.71% institutional ownership. According to the most recent insider trade that took place on Oct 31 ’25, this organization’s Senior Managing Director sold 160,000 shares at the rate of 23.56, making the entire transaction reach 3,768,832 in total value, affecting insider ownership by 192.
Invesco Ltd (IVZ) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.58 per share during the current fiscal year.
Invesco Ltd’s EPS increase for this current 12-month fiscal period is 16.30% and is forecasted to reach 2.61 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 20.62% through the next 5 years, which can be compared against the -1.69% growth it accomplished over the previous five years trading on the market.
Invesco Ltd (NYSE: IVZ) Trading Performance Indicators
Let’s observe the current performance indicators for Invesco Ltd (IVZ). It’s Quick Ratio in the last reported quarter now stands at 0.98. Alongside those numbers, its PE Ratio stands at $19.18, and its Beta score is 1.67. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.00. Similarly, its price to free cash flow for trailing twelve months is now 10.14.
In the same vein, IVZ’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.47, a figure that is expected to reach 0.58 in the next quarter, and analysts are predicting that it will be 2.61 at the market close of one year from today.
